Literature DB >> 1348421

Involvement of 5-HT1B receptors in the anticonflict effect of m-CPP in rats.

E Chojnacka-Wójcik1, A Kłodzińska.   

Abstract

The anticonflict activity of m-CPP, a non-selective agonist of 5-HT receptors, was studied in the drinking conflict test in rats. m-CPP administered in doses of 0.125-0.5 mg/kg increased the number of punished licks, the maximum effect having been observed after a dose of 0.25 mg/kg. The anticonflict effect of m-CPP (0.25 mg/kg) was antagonized by the non-selective 5-HT antagonist metergoline (1-4 mg/kg) and by the beta-adrenoceptor blocker SDZ 21009 (2 and 4 mg/kg) with affinity for 5-HT1A and 5-HT1B receptors. On the other hand, the 5-HT1A receptor antagonist NAN-190 (0.5 and 1 mg/kg), the 5-HT2 receptor antagonist ritanserin (0.25 and 0.5 mg/kg), and the beta-blockers betaxolol (8 mg/kg) and ICI 118,551 (8 mg/kg) with no affinity for 5-HT receptors did not affect the effect of m-CPP. The effect of m-CPP was not modified, either, in animals with the 5-HT lesion produced by p-chloroamphetamine. These results suggest that the anticonflict effect of m-CPP described above results from stimulation of 5-HT1B receptors--most probably these which are located postsynaptically.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1348421     DOI: 10.1007/bf01245010

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  29 in total

1.  Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors.

Authors:  G A Kennett; G Curzon
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

2.  Disposition and pharmacological effects of m-Chlorophenylpiperazine in rats.

Authors:  R W Fuller; H D Snoddy; N R Mason; J E Owen
Journal:  Neuropharmacology       Date:  1981-02       Impact factor: 5.250

3.  Evidence for the involvement of 5-HT1A receptors in the anticonflict effect of ipsapirone in rats.

Authors:  E Chojnacka-Wójcik; E Przegaliński
Journal:  Neuropharmacology       Date:  1991-07       Impact factor: 5.250

4.  Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors.

Authors:  P J Conn; E Sanders-Bush
Journal:  J Pharmacol Exp Ther       Date:  1987-08       Impact factor: 4.030

5.  Determination of selective and nonselective compounds for the 5-HT 1A and 5-HT 1B receptor subtypes in rat frontal cortex.

Authors:  M A Sills; B B Wolfe; A Frazer
Journal:  J Pharmacol Exp Ther       Date:  1984-12       Impact factor: 4.030

6.  The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

Authors:  M D Tricklebank; C Forler; J R Fozard
Journal:  Eur J Pharmacol       Date:  1984-11-13       Impact factor: 4.432

7.  5-HT1B agonists induce anorexia at a postsynaptic site.

Authors:  G A Kennett; C T Dourish; G Curzon
Journal:  Eur J Pharmacol       Date:  1987-09-23       Impact factor: 4.432

8.  Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.

Authors:  D Hoyer; G Engel; H O Kalkman
Journal:  Eur J Pharmacol       Date:  1985-11-26       Impact factor: 4.432

9.  Exploratory hypoactivity induced by m-trifluoromethylphenylpiperazine (TFMPP) and m-chlorophenylpiperazine (m-CPP).

Authors:  A Kłodzińska; T Jaros; E Chojnacka-Wójcik; J Maj
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1989

10.  NAN-190: an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).

Authors:  R A Glennon; N A Naiman; M E Pierson; M Titeler; R A Lyon; E Weisberg
Journal:  Eur J Pharmacol       Date:  1988-09-23       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.